ICON expects market conditions to remain similar through year-end, assuming persistent cancellation rates and mixed timing on biotech conversions. The company raised its full year revenue guidance to ...

Earnings Call Insights: ICON Public Limited Company (ICLR) Q2 2025 Full-year revenue guidance was updated to a new range of $7.85 billion at the low end and $8.15 billion at the high end, "increasing ...

Icon has been hit hard by the disruptions from the global pandemic, and it’s starting to show up in the balance sheet. The CRO, based in Ireland, said in its second-quarter financials that revenue was ...

Yet another CRO giant has taken a revenue hit due to a customer demand dip. Irish clinical research organization Icon reported third-quarter revenue of $2.03 billion, underperforming analyst ...

Earnings Call Insights: ICON Public Limited Company (ICLR) Q3 2025 Steven Cutler reflected on his tenure, noting ICON's growth from 8,500 to 40,000 employees and its rise in industry ranking. He ...

Full-year revenue guidance was updated to a new range of $7.85 billion at the low end and $8.15 billion at the high end, "increasing the midpoint to $8 billion." The full-year adjusted earnings per ...